THYROID, PORCINE

THYROID, PORCINE was reported 10773 times

THYROID, PORCINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRI-IODOTHYRONINE INCREASED 31 0.0777
1 TRI-IODOTHYRONINE DECREASED 33 0.0632
2 TRI-IODOTHYRONINE ABNORMAL 7 0.0579
3 THYROXINE DECREASED 23 0.0371
4 THYROID HORMONES DECREASED 22 0.0275
5 BLOOD THYROID STIMULATING HORMONE ABNORMAL 44 0.0239
6 MANUFACTURING ISSUE 8 0.0172
7 THYROXINE INCREASED 12 0.0170
8 THYROID HORMONES INCREASED 17 0.0162
9 AUTOIMMUNE THYROIDITIS 59 0.0156
10 THYROXINE FREE DECREASED 8 0.0142
11 REACTION TO PRESERVATIVES 11 0.0135
12 BLOOD THYROID STIMULATING HORMONE DECREASED 61 0.0134
13 THYROIDECTOMY 23 0.0132
14 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 10 0.0122
15 BONE CYST 11 0.0117
16 PRE-EXISTING CONDITION IMPROVED 70 0.0112
17 PERNICIOUS ANAEMIA 7 0.0110
18 NAIL GROWTH ABNORMAL 12 0.0109
19 BLOOD THYROID STIMULATING HORMONE INCREASED 100 0.0109
20 THYROID FUNCTION TEST ABNORMAL 42 0.0101
21 LYME DISEASE 33 0.0099
22 CIRCADIAN RHYTHM SLEEP DISORDER 8 0.0097
23 ALLERGY TO CHEMICALS 12 0.0096
24 PERIORBITAL PAIN 8 0.0094
25 ENDOCRINE OPHTHALMOPATHY 7 0.0081
26 PRODUCT MEASURED POTENCY ISSUE 8 0.0079
27 ADRENAL DISORDER 15 0.0078
28 GLUTEN SENSITIVITY 10 0.0070
29 THYROTOXIC CRISIS 8 0.0070
30 ALLERGIC REACTION TO EXCIPIENT 14 0.0070
31 BLADDER PROLAPSE 8 0.0065
32 GOITRE 24 0.0059
33 THYROID DISORDER 90 0.0058
34 CERVICAL SPINAL STENOSIS 10 0.0058
35 MAST CELL ACTIVATION SYNDROME 8 0.0057
36 VASCULAR INJURY 8 0.0055
37 COMPLEX REGIONAL PAIN SYNDROME 8 0.0054
38 PRODUCT SIZE ISSUE 29 0.0054
39 TRICHORRHEXIS 15 0.0054
40 SNORING 20 0.0053
41 VULVOVAGINAL DRYNESS 17 0.0053
42 PRODUCT ODOUR ABNORMAL 55 0.0052
43 RECALLED PRODUCT 9 0.0052
44 CATAPLEXY 7 0.0049
45 EYELID PAIN 10 0.0049
46 INVESTIGATION ABNORMAL 7 0.0049
47 PRODUCT FORMULATION ISSUE 32 0.0048
48 PRODUCT ADMINISTRATION INTERRUPTED 38 0.0048
49 OBSTRUCTIVE SLEEP APNOEA SYNDROME 7 0.0048
50 MENOPAUSE 12 0.0047
51 INFUSION SITE BRUISING 10 0.0046
52 REACTION TO DRUG EXCIPIENTS 10 0.0046
53 MIDDLE EAR EFFUSION 10 0.0045
54 HORMONE LEVEL ABNORMAL 21 0.0043
55 HYPOTHYROIDISM 136 0.0043
56 INFUSION SITE HAEMORRHAGE 14 0.0043
57 GASTRIC DILATATION 7 0.0042
58 ANIMAL BITE 11 0.0041
59 VOCAL CORD DISORDER 8 0.0041
60 INFUSION SITE DISCHARGE 7 0.0040
61 PARANASAL SINUS DISCOMFORT 15 0.0040
62 TEMPERATURE INTOLERANCE 40 0.0039
63 MENOPAUSAL SYMPTOMS 9 0.0039
64 INFUSION SITE PRURITUS 12 0.0038
65 HYPERTHYROIDISM 55 0.0038
66 VITAMIN D DEFICIENCY 37 0.0038
67 SINUS OPERATION 9 0.0038
68 COELIAC DISEASE 37 0.0038
69 HYPOPNOEA 13 0.0037
70 PRODUCT COLOUR ISSUE 19 0.0037
71 JOINT NOISE 7 0.0036
72 HAIR TEXTURE ABNORMAL 47 0.0035
73 SLEEP APNOEA SYNDROME 67 0.0035
74 EAR DISCOMFORT 36 0.0035
75 PHARYNGEAL DISORDER 10 0.0035
76 HEREDITARY ANGIOEDEMA 37 0.0034
77 MULTIPLE ALLERGIES 27 0.0034
78 ORAL SURGERY 8 0.0034
79 HANGOVER 12 0.0034
80 CARDIAC FLUTTER 22 0.0034
81 HAIR DISORDER 28 0.0034
82 EAR CONGESTION 9 0.0033
83 PRODUCT LOT NUMBER ISSUE 7 0.0032
84 FOREIGN BODY SENSATION IN EYES 20 0.0031
85 THYROID MASS 12 0.0031
86 LACTOSE INTOLERANCE 8 0.0031
87 APPLICATION SITE URTICARIA 7 0.0031
88 LIPOMA 8 0.0031
89 HAEMATOCRIT INCREASED 7 0.0031
90 NERVE COMPRESSION 28 0.0030
91 REACTION TO EXCIPIENT 7 0.0030
92 POST-TRAUMATIC STRESS DISORDER 20 0.0030
93 FOOD ALLERGY 23 0.0030
94 BLOOD SODIUM INCREASED 8 0.0030
95 MASTICATION DISORDER 9 0.0029
96 WRONG PATIENT RECEIVED MEDICATION 8 0.0029
97 ONYCHOCLASIS 20 0.0029
98 SWELLING OF EYELID 18 0.0029
99 PHARYNGEAL SWELLING 28 0.0029
100 PALPITATIONS 331 0.0028
101 VITAMIN D DECREASED 24 0.0028
102 EYELID IRRITATION 7 0.0028
103 FEELING JITTERY 53 0.0028
104 SEASONAL ALLERGY 39 0.0028
105 BRAIN FOG 43 0.0027
106 FEELING OF BODY TEMPERATURE CHANGE 16 0.0027
107 NEAR DEATH EXPERIENCE 9 0.0027
108 CHOKING SENSATION 15 0.0027
109 HYPERACUSIS 10 0.0027
110 CHRONIC SINUSITIS 10 0.0027
111 CRANIOCEREBRAL INJURY 8 0.0026
112 PROTEIN TOTAL INCREASED 7 0.0026
113 TEMPOROMANDIBULAR JOINT SYNDROME 7 0.0026
114 PRODUCT SUBSTITUTION ISSUE 150 0.0026
115 BREAST SWELLING 7 0.0026
116 NEPHROGENIC ANAEMIA 12 0.0026
117 HAIR COLOUR CHANGES 32 0.0026
118 MUSCLE RUPTURE 10 0.0026
119 FIBROMYALGIA 62 0.0025
120 HORDEOLUM 11 0.0025
121 RESTLESS LEGS SYNDROME 46 0.0025
122 SINUS HEADACHE 15 0.0025
123 APPARENT DEATH 9 0.0025
124 INTERVERTEBRAL DISC DEGENERATION 23 0.0025
125 LOOSE TOOTH 8 0.0025
126 SINUS DISORDER 49 0.0025
127 OCULAR DISCOMFORT 27 0.0024
128 ERYTHEMA OF EYELID 13 0.0024
129 TONGUE DISCOMFORT 10 0.0024
130 ATYPICAL PNEUMONIA 7 0.0023
131 HEART RATE ABNORMAL 13 0.0023
132 MAJOR DEPRESSION 17 0.0023
133 TENSION HEADACHE 10 0.0023
134 TACHYPHRENIA 8 0.0023
135 MALABSORPTION 12 0.0023
136 SINUS CONGESTION 31 0.0023
137 SKIN ODOUR ABNORMAL 9 0.0023
138 FOOD CRAVING 12 0.0023
139 OESOPHAGEAL PAIN 9 0.0023
140 MENISCUS INJURY 14 0.0023
141 SCOLIOSIS 14 0.0023
142 AUTOIMMUNE DISORDER 22 0.0023
143 BLOOD BLISTER 7 0.0022
144 MADAROSIS 26 0.0022
145 HUNGER 31 0.0022
146 BRUXISM 12 0.0022
147 FOOT OPERATION 11 0.0022
148 BLOOD MAGNESIUM DECREASED 19 0.0022
149 WEIGHT FLUCTUATION 23 0.0022
150 MUSCLE STRAIN 19 0.0022
151 UPPER-AIRWAY COUGH SYNDROME 18 0.0022
152 FOOD INTOLERANCE 8 0.0022
153 PRODUCT PHYSICAL ISSUE 44 0.0022
154 ROTATOR CUFF SYNDROME 28 0.0022
155 VULVOVAGINAL PRURITUS 11 0.0022
156 SYNOVIAL CYST 10 0.0022
157 WEIGHT LOSS POOR 11 0.0021
158 EAR INFECTION 57 0.0021
159 INFUSION SITE ERYTHEMA 18 0.0021
160 EYE PAIN 120 0.0021
161 BLADDER DISORDER 21 0.0021
162 EYE IRRITATION 121 0.0021
163 MUSCLE DISORDER 17 0.0021
164 RECALLED PRODUCT ADMINISTERED 20 0.0021
165 THERAPEUTIC RESPONSE UNEXPECTED 94 0.0021
166 VULVOVAGINAL PAIN 10 0.0021
167 CONCUSSION 16 0.0021
168 INFUSION SITE SWELLING 13 0.0021
169 THERAPEUTIC PRODUCT EFFECT VARIABLE 8 0.0021
170 NIGHT SWEATS 66 0.0020
171 FUNCTIONAL GASTROINTESTINAL DISORDER 7 0.0020
172 LIGAMENT SPRAIN 20 0.0020
173 FEELING DRUNK 15 0.0020
174 NASAL DISCOMFORT 16 0.0020
175 FORMICATION 14 0.0020
176 SINUSITIS 206 0.0020
177 SYMPTOM RECURRENCE 12 0.0020
178 GENERAL SYMPTOM 15 0.0020
179 FEELING ABNORMAL 478 0.0020
180 PRODUCT TASTE ABNORMAL 27 0.0020
181 VITAMIN B12 DEFICIENCY 8 0.0020
182 MACULOPATHY 7 0.0020
183 UNEVALUABLE EVENT 149 0.0020
184 BODY HEIGHT DECREASED 21 0.0020
185 INCREASED UPPER AIRWAY SECRETION 10 0.0019
186 BLOOD CALCIUM INCREASED 17 0.0019
187 SPINAL OSTEOARTHRITIS 17 0.0019
188 ROSACEA 9 0.0019
189 BODY TEMPERATURE DECREASED 19 0.0019
190 PRODUCT DISPENSING ERROR 42 0.0019
191 HEART RATE INCREASED 191 0.0019
192 EYE DISCHARGE 20 0.0019
193 DISABILITY 38 0.0019
194 NASAL DRYNESS 12 0.0019
195 GASTROINTESTINAL PAIN 21 0.0019
196 PANIC ATTACK 69 0.0019
197 WOUND HAEMORRHAGE 7 0.0019
198 ALOPECIA 371 0.0019
199 MUSCLE FATIGUE 8 0.0019
200 HAIR GROWTH ABNORMAL 13 0.0019
201 INTERVERTEBRAL DISC DISORDER 8 0.0019
202 HEAD DISCOMFORT 33 0.0019
203 HEART RATE IRREGULAR 42 0.0019
204 FRUSTRATION TOLERANCE DECREASED 15 0.0019
205 HYSTERECTOMY 16 0.0018
206 OSTEOPENIA 28 0.0018
207 PARANASAL SINUS HYPERSECRETION 7 0.0018
208 FEELING COLD 51 0.0018
209 TONGUE DISCOLOURATION 8 0.0018
210 DIVERTICULUM INTESTINAL 8 0.0018
211 CLAVICLE FRACTURE 7 0.0018
212 NECK PAIN 102 0.0018
213 DRY EYE 91 0.0018
214 HAEMORRHAGIC ANAEMIA 8 0.0018
215 HYPERSOMNIA 52 0.0018
216 LIGAMENT RUPTURE 8 0.0018
217 LACERATION 17 0.0018
218 VULVOVAGINAL BURNING SENSATION 11 0.0018
219 MIGRAINE 172 0.0018
220 MUSCLE TIGHTNESS 29 0.0018
221 INFUSION SITE PAIN 23 0.0018
222 VULVOVAGINAL MYCOTIC INFECTION 7 0.0018
223 UTERINE LEIOMYOMA 13 0.0018
224 HIATUS HERNIA 23 0.0018
225 SUSPECTED COUNTERFEIT PRODUCT 7 0.0018
226 PERIORBITAL SWELLING 10 0.0018
227 TOOTH ABSCESS 18 0.0018
228 DRUG EFFECT DELAYED 8 0.0018
229 PHOTOPHOBIA 33 0.0018
230 EAR PAIN 34 0.0017
231 FOREIGN BODY 7 0.0017
232 PERIPHERAL COLDNESS 24 0.0017
233 TRIGEMINAL NEURALGIA 7 0.0017
234 ORAL DISCOMFORT 24 0.0017
235 RENAL FUNCTION TEST ABNORMAL 8 0.0017
236 APPLICATION SITE DISCOLOURATION 7 0.0017
237 SCAR 29 0.0017
238 SPINAL COLUMN STENOSIS 8 0.0017
239 SKIN ABRASION 8 0.0017
240 BREAST PAIN 18 0.0017
241 BLOOD PRESSURE INCREASED 257 0.0017
242 TINNITUS 77 0.0017
243 SOMNAMBULISM 11 0.0017
244 EYELID PTOSIS 17 0.0017
245 DRY THROAT 17 0.0017
246 HEARING IMPAIRED 10 0.0017
247 DERMATITIS CONTACT 19 0.0017
248 MIDDLE INSOMNIA 31 0.0017
249 FACIAL PARALYSIS 14 0.0016
250 HEPATIC PAIN 7 0.0016
251 SHOULDER OPERATION 7 0.0016
252 BLOOD TEST ABNORMAL 23 0.0016
253 ABNORMAL SENSATION IN EYE 7 0.0016
254 VITREOUS FLOATERS 16 0.0016
255 NERVOUSNESS 85 0.0016
256 POOR QUALITY SLEEP 35 0.0016
257 APPLICATION SITE BURN 8 0.0016
258 BRONCHITIS 120 0.0016
259 OBSESSIVE-COMPULSIVE DISORDER 13 0.0016
260 POOR QUALITY PRODUCT ADMINISTERED 17 0.0016
261 WEIGHT INCREASED 361 0.0016
262 INJECTION SITE INFLAMMATION 8 0.0016
263 HOT FLUSH 121 0.0016
264 MUSCLE TWITCHING 37 0.0016
265 FLUID INTAKE REDUCED 8 0.0016
266 BLOOD POTASSIUM DECREASED 48 0.0016
267 DRUG TOLERANCE 8 0.0016
268 KIDNEY INFECTION 31 0.0016
269 EXTRASYSTOLES 11 0.0016
270 BOWEL MOVEMENT IRREGULARITY 12 0.0016
271 EXERCISE TOLERANCE DECREASED 9 0.0016
272 ILLNESS 161 0.0016
273 LABORATORY TEST ABNORMAL 46 0.0016
274 IRON DEFICIENCY 7 0.0016
275 INTERVERTEBRAL DISC PROTRUSION 34 0.0016
276 SKIN HAEMORRHAGE 23 0.0016
277 INSOMNIA 413 0.0015
278 TENDONITIS 24 0.0015
279 VARICOSE VEIN 8 0.0015
280 SPINAL OPERATION 19 0.0015
281 IMPAIRED GASTRIC EMPTYING 21 0.0015
282 TENDERNESS 16 0.0015
283 TENDON DISORDER 10 0.0015
284 IMPAIRED QUALITY OF LIFE 22 0.0015
285 ANXIETY 435 0.0015
286 DYSPAREUNIA 7 0.0015
287 TONGUE DISORDER 11 0.0015
288 DYSGRAPHIA 10 0.0015
289 CATARACT OPERATION 9 0.0015
290 ACTIVITIES OF DAILY LIVING IMPAIRED 30 0.0015
291 EMBEDDED DEVICE 15 0.0015
292 MUSCULOSKELETAL DISCOMFORT 26 0.0015
293 INSURANCE ISSUE 23 0.0015
294 THINKING ABNORMAL 28 0.0015
295 GASTROINTESTINAL MOTILITY DISORDER 8 0.0015
296 FOOD POISONING 8 0.0015
297 TIBIA FRACTURE 7 0.0015
298 TOOTHACHE 27 0.0015
299 OVERWEIGHT 8 0.0015
300 NAIL DISORDER 13 0.0015
301 ANKLE FRACTURE 23 0.0015
302 ARTHROPOD BITE 11 0.0015
303 GINGIVITIS 8 0.0015
304 PRURITUS GENERALISED 32 0.0015
305 COLD SWEAT 26 0.0015
306 JAW DISORDER 8 0.0015
307 EYE MOVEMENT DISORDER 10 0.0015
308 VERTIGO 89 0.0015
309 PRODUCT USE COMPLAINT 23 0.0015
310 LIMB OPERATION 7 0.0015
311 PAROSMIA 11 0.0015
312 FOREIGN BODY IN REPRODUCTIVE TRACT 13 0.0015
313 HEAD INJURY 46 0.0015
314 SWELLING FACE 94 0.0014
315 LARGE INTESTINE POLYP 10 0.0014
316 FUNGAL INFECTION 48 0.0014
317 GASTROENTERITIS VIRAL 26 0.0014
318 NEURALGIA 35 0.0014
319 HYPERHIDROSIS 185 0.0014
320 SENSATION OF FOREIGN BODY 12 0.0014
321 EXOSTOSIS 13 0.0014
322 QUALITY OF LIFE DECREASED 19 0.0014
323 PAIN IN JAW 40 0.0014
324 OCULAR HYPERAEMIA 67 0.0014
325 LETHARGY 81 0.0014
326 THERAPEUTIC PRODUCT EFFECT DECREASED 63 0.0014
327 DYSSTASIA 41 0.0014
328 SCAB 16 0.0014
329 PSYCHOLOGICAL TRAUMA 12 0.0014
330 LACRIMATION INCREASED 42 0.0014
331 PSYCHOMOTOR HYPERACTIVITY 23 0.0014
332 SURGERY 81 0.0014
333 FATIGUE 1075 0.0014
334 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 66 0.0014
335 OSTEOARTHRITIS 58 0.0014
336 DYSPHONIA 80 0.0014
337 IMMUNE SYSTEM DISORDER 18 0.0014
338 JOINT INJURY 29 0.0014
339 TRISMUS 7 0.0014
340 DEPRESSION 308 0.0014
341 AFFECT LABILITY 13 0.0013
342 ABDOMINAL DISTENSION 141 0.0013
343 PLEURISY 8 0.0013
344 ABNORMAL FAECES 11 0.0013
345 BLOOD CHOLESTEROL INCREASED 62 0.0013
346 BLOOD PRESSURE INADEQUATELY CONTROLLED 8 0.0013
347 EYE INFECTION 15 0.0013
348 VISION BLURRED 182 0.0013
349 LIMB INJURY 36 0.0013
350 APPLICATION SITE PRURITUS 30 0.0013
351 RESPIRATORY TRACT CONGESTION 21 0.0013
352 TENDON PAIN 10 0.0013
353 RENAL PAIN 14 0.0013
354 IMPAIRED DRIVING ABILITY 15 0.0013
355 CYSTITIS 42 0.0013
356 PRESYNCOPE 32 0.0013
357 OSTEOPOROSIS 54 0.0013
358 WITHDRAWAL SYNDROME 55 0.0013
359 ARTHRITIS 103 0.0013
360 IRRITABLE BOWEL SYNDROME 28 0.0013
361 MUSCULOSKELETAL PAIN 68 0.0013
362 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
363 HEADACHE 810 0.0013
364 APHONIA 18 0.0013
365 FEELING HOT 79 0.0013
366 SKIN LACERATION 14 0.0013
367 VAGINAL DISCHARGE 13 0.0013
368 BURNING SENSATION 90 0.0013
369 MOOD ALTERED 35 0.0013
370 MENTAL IMPAIRMENT 31 0.0013
371 TREMOR 212 0.0013
372 BLOOD SODIUM DECREASED 24 0.0013
373 AFFECTIVE DISORDER 10 0.0013
374 BLEPHAROSPASM 8 0.0013
375 THROAT IRRITATION 57 0.0013
376 MUSCLE SPASMS 233 0.0013
377 EYE SWELLING 47 0.0013
378 PRODUCT QUALITY ISSUE 171 0.0013
379 DRY MOUTH 102 0.0013
380 GINGIVAL PAIN 10 0.0013
381 MACULAR DEGENERATION 15 0.0013
382 UPPER RESPIRATORY TRACT INFECTION 58 0.0013
383 INTRAOCULAR PRESSURE INCREASED 16 0.0013
384 EYE PRURITUS 42 0.0012
385 PERIPHERAL SWELLING 192 0.0012
386 VISUAL FIELD DEFECT 9 0.0012
387 ANOSMIA 18 0.0012
388 POOR QUALITY DRUG ADMINISTERED 8 0.0012
389 APATHY 18 0.0012
390 SCRATCH 13 0.0012
391 FACIAL PAIN 11 0.0012
392 JOINT DISLOCATION 13 0.0012
393 COGNITIVE DISORDER 57 0.0012
394 BLINDNESS TRANSIENT 9 0.0012
395 RETCHING 26 0.0012
396 DISEASE RECURRENCE 58 0.0012
397 BEDRIDDEN 16 0.0012
398 CARPAL TUNNEL SYNDROME 17 0.0012
399 TOOTH INFECTION 16 0.0012
400 ADVERSE DRUG REACTION 109 0.0012
401 WALKING AID USER 8 0.0012
402 FOOT FRACTURE 23 0.0012
403 MOUTH SWELLING 7 0.0012
404 BLOOD URINE PRESENT 23 0.0012
405 PHOTOSENSITIVITY REACTION 20 0.0012
406 INABILITY TO AFFORD MEDICATION 12 0.0012
407 APPETITE DISORDER 8 0.0012
408 METABOLIC DISORDER 7 0.0012
409 DISTURBANCE IN ATTENTION 65 0.0012
410 UPPER LIMB FRACTURE 24 0.0012
411 LOCAL SWELLING 21 0.0012
412 OROPHARYNGEAL PAIN 111 0.0012
413 MEMORY IMPAIRMENT 163 0.0012
414 ENERGY INCREASED 7 0.0012
415 CRYING 43 0.0012
416 ANGER 40 0.0012
417 URINARY INCONTINENCE 35 0.0012
418 TOOTH FRACTURE 13 0.0012
419 PARAESTHESIA ORAL 17 0.0012
420 SLEEP DISORDER 83 0.0012
421 FLANK PAIN 11 0.0012
422 BLOOD TESTOSTERONE DECREASED 8 0.0012
423 INITIAL INSOMNIA 12 0.0012
424 BLOOD PRESSURE FLUCTUATION 28 0.0012
425 MUSCULOSKELETAL CHEST PAIN 18 0.0012
426 BALANCE DISORDER 100 0.0012
427 THROAT TIGHTNESS 31 0.0011
428 DIZZINESS 571 0.0011
429 TENDON RUPTURE 14 0.0011
430 DYSMENORRHOEA 15 0.0011
431 LYMPHADENOPATHY 40 0.0011
432 PHARYNGITIS 14 0.0011
433 HYPOAESTHESIA ORAL 17 0.0011
434 NIGHTMARE 39 0.0011
435 POLLAKIURIA 47 0.0011
436 WEIGHT DECREASED 314 0.0011
437 TOOTH DISORDER 25 0.0011
438 AGEUSIA 28 0.0011
439 HYPOAESTHESIA 168 0.0011
440 SKIN ULCER 29 0.0011
441 PARAESTHESIA 176 0.0011
442 PARALYSIS 16 0.0011
443 MUSCULAR WEAKNESS 127 0.0011
444 RHINITIS 9 0.0011
445 ANAL INCONTINENCE 10 0.0011
446 CONSTIPATION 242 0.0011
447 SPINAL PAIN 13 0.0011
448 PHARYNGITIS STREPTOCOCCAL 12 0.0011
449 CATARACT 66 0.0011
450 PHOTOPSIA 7 0.0011
451 COMPLICATION OF DEVICE INSERTION 22 0.0011
452 MYALGIA 187 0.0011
453 JOINT SWELLING 132 0.0011
454 NEUROPATHY PERIPHERAL 104 0.0011
455 APHASIA 33 0.0011
456 AMNESIA 71 0.0011
457 ABDOMINAL DISCOMFORT 183 0.0011
458 ACCIDENT 13 0.0011
459 SPINAL COMPRESSION FRACTURE 9 0.0011
460 MENSTRUAL DISORDER 9 0.0011
461 PRESCRIBED OVERDOSE 21 0.0011
462 ARTHRALGIA 451 0.0011
463 WRIST FRACTURE 13 0.0011
464 DIPLOPIA 28 0.0011
465 DYSPEPSIA 106 0.0011
466 HERPES SIMPLEX 7 0.0011
467 IMPAIRED WORK ABILITY 23 0.0011
468 COORDINATION ABNORMAL 15 0.0011
469 PULMONARY MASS 16 0.0011
470 URINARY TRACT INFECTION 183 0.0011
471 ADRENAL INSUFFICIENCY 13 0.0011
472 EMOTIONAL DISORDER 33 0.0011
473 SKIN INFECTION 12 0.0011
474 HYPERTENSION 226 0.0011
475 IMPAIRED HEALING 35 0.0011
476 THIRST 19 0.0011
477 DYSGEUSIA 79 0.0011
478 INTENTIONAL DOSE OMISSION 30 0.0011
479 RHINORRHOEA 68 0.0011
480 RASH PRURITIC 57 0.0011
481 AORTIC ANEURYSM 8 0.0011
482 URTICARIA 176 0.0010
483 PELVIC PAIN 19 0.0010
484 BACK DISORDER 17 0.0010
485 LOWER LIMB FRACTURE 20 0.0010
486 CARDIAC MURMUR 9 0.0010
487 PHARYNGEAL OEDEMA 16 0.0010
488 BRONCHIECTASIS 7 0.0010
489 NASAL CONGESTION 61 0.0010
490 SECRETION DISCHARGE 13 0.0010
491 WRONG PRODUCT ADMINISTERED 7 0.0010
492 PRODUCT ADHESION ISSUE 37 0.0010
493 ULCER HAEMORRHAGE 7 0.0010
494 LOW DENSITY LIPOPROTEIN INCREASED 8 0.0010
495 DYSURIA 38 0.0010
496 PRODUCT LABEL ISSUE 7 0.0010
497 RASH MACULAR 36 0.0010
498 ORAL PAIN 23 0.0010
499 ABNORMAL LOSS OF WEIGHT 7 0.0010
500 COVID-19 180 0.0010
501 SNEEZING 23 0.0010
502 SKIN FISSURES 20 0.0010
503 VIRAL INFECTION 34 0.0010
504 DECREASED ACTIVITY 11 0.0010
505 ASTHENIA 383 0.0010
506 CONTUSION 98 0.0010
507 KNEE OPERATION 10 0.0010
508 NAUSEA 800 0.0010
509 FURUNCLE 8 0.0010
510 BACK PAIN 234 0.0010
511 CANDIDA INFECTION 17 0.0010
512 ATRIAL FIBRILLATION 98 0.0010
513 ULCER 16 0.0010
514 SUICIDAL IDEATION 92 0.0010
515 DRUG INTOLERANCE 97 0.0010
516 MALAISE 440 0.0010
517 SOMNOLENCE 202 0.0010
518 BONE LOSS 15 0.0010
519 HEART RATE DECREASED 35 0.0010
520 CHEST DISCOMFORT 102 0.0010
521 PRODUCT DOSE OMISSION 65 0.0010
522 THERAPEUTIC RESPONSE SHORTENED 33 0.0010
523 DENTAL CARIES 11 0.0010
524 SWELLING 93 0.0010
525 SWOLLEN TONGUE 31 0.0010
526 NERVE INJURY 11 0.0010
527 BURSITIS 12 0.0010
528 NOCTURIA 12 0.0010
529 GAIT DISTURBANCE 189 0.0010
530 PARANOIA 17 0.0010
531 DIVERTICULUM 7 0.0010
532 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 70 0.0010
533 RASH PAPULAR 22 0.0010
534 SLUGGISHNESS 10 0.0010
535 BRAIN NEOPLASM 9 0.0010
536 HIP ARTHROPLASTY 15 0.0010
537 BLOOD CALCIUM DECREASED 11 0.0010
538 MUSCLE SPASTICITY 12 0.0010
539 CARDIOMEGALY 12 0.0010
540 HYPERSENSITIVITY 181 0.0010
541 HICCUPS 8 0.0010
542 HAEMORRHOIDS 19 0.0010
543 ORAL HERPES 19 0.0010
544 EYE DISORDER 32 0.0010
545 FALL 323 0.0010
546 VAGINAL HAEMORRHAGE 42 0.0010
547 FEAR 26 0.0010
548 POOR VENOUS ACCESS 10 0.0010
549 PAIN 592 0.0010
550 APPENDICITIS 9 0.0010
551 FLUID RETENTION 49 0.0010
552 NASOPHARYNGITIS 177 0.0010
553 RESPIRATORY TRACT INFECTION 25 0.0010
554 INTENTIONAL PRODUCT MISUSE 84 0.0010
555 INTENTIONAL PRODUCT USE ISSUE 84 0.0010
556 ROAD TRAFFIC ACCIDENT 40 0.0010
557 ORAL DISORDER 7 0.0010
558 IRRITABILITY 57 0.0009
559 INFLUENZA LIKE ILLNESS 78 0.0009
560 GOUT 17 0.0009
561 ABDOMINAL PAIN UPPER 195 0.0009
562 LOWER GASTROINTESTINAL HAEMORRHAGE 7 0.0009
563 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
564 CHEST PAIN 175 0.0009
565 FULL BLOOD COUNT DECREASED 19 0.0009
566 FEEDING DISORDER 19 0.0009
567 PSORIATIC ARTHROPATHY 38 0.0009
568 DRUG EFFECT INCOMPLETE 34 0.0009
569 THERAPY CESSATION 48 0.0009
570 HYDRONEPHROSIS 7 0.0009
571 EXPIRED PRODUCT ADMINISTERED 31 0.0009
572 LIP SWELLING 31 0.0009
573 BREAST TENDERNESS 7 0.0009
574 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 66 0.0009
575 DYSPHAGIA 88 0.0009
576 BONE PAIN 54 0.0009
577 NODULE 12 0.0009
578 DISCOMFORT 56 0.0009
579 MENORRHAGIA 18 0.0009
580 APPLICATION SITE ERYTHEMA 24 0.0009
581 NEPHROLITHIASIS 42 0.0009
582 THERAPY CHANGE 9 0.0009
583 THYROID CANCER 11 0.0009
584 PAIN IN EXTREMITY 269 0.0009
585 HOSPICE CARE 9 0.0009
586 LOCALISED INFECTION 22 0.0009
587 LUNG INFILTRATION 8 0.0009
588 ADVERSE REACTION 12 0.0009
589 LIMB DISCOMFORT 28 0.0009
590 FOOT DEFORMITY 10 0.0009
591 HIP FRACTURE 29 0.0009
592 PROCEDURAL PAIN 25 0.0009
593 SKIN DISORDER 30 0.0009
594 BRAIN INJURY 9 0.0009
595 VISUAL IMPAIRMENT 111 0.0009
596 MALIGNANT MELANOMA 12 0.0009
597 MALNUTRITION 10 0.0009
598 MUSCULOSKELETAL DISORDER 17 0.0009
599 EMPHYSEMA 9 0.0009
600 INCREASED APPETITE 17 0.0009
601 LOSS OF LIBIDO 8 0.0009
602 GENERALISED OEDEMA 11 0.0009
603 CHILLS 104 0.0009
604 COMPLICATION OF DEVICE REMOVAL 16 0.0009
605 DRUG PRESCRIBING ERROR 17 0.0009
606 COUGH 248 0.0009
607 CHOLELITHIASIS 29 0.0009
608 DRY SKIN 118 0.0009
609 MOTOR DYSFUNCTION 9 0.0009
610 WRONG TECHNIQUE IN DRUG USAGE PROCESS 32 0.0009
611 METRORRHAGIA 15 0.0009
612 BONE DISORDER 16 0.0009
613 MICTURITION URGENCY 10 0.0009
614 SENSORY DISTURBANCE 14 0.0009
615 INFLUENZA 97 0.0009
616 DEHYDRATION 116 0.0009
617 INCREASED TENDENCY TO BRUISE 8 0.0009
618 PRURITUS 334 0.0009
619 VENTRICULAR EXTRASYSTOLES 9 0.0009
620 DIVERTICULITIS 24 0.0009
621 BLOOD COUNT ABNORMAL 13 0.0009
622 BLOOD PRESSURE ABNORMAL 17 0.0009
623 KNEE ARTHROPLASTY 18 0.0009
624 DRUG EFFECT DECREASED 46 0.0009
625 DRUG ADMINISTERED AT INAPPROPRIATE SITE 9 0.0009
626 INJECTION SITE BRUISING 68 0.0009
627 HYPERAESTHESIA 7 0.0009
628 DEPRESSED MOOD 45 0.0009
629 ARTERIOSCLEROSIS 8 0.0008
630 OEDEMA 46 0.0008
631 SPINAL DISORDER 8 0.0008
632 BLOOD IRON DECREASED 10 0.0008
633 PRODUCT ADMINISTRATION ERROR 17 0.0008
634 STOMATITIS 51 0.0008
635 SPEECH DISORDER 44 0.0008
636 HYPOACUSIS 36 0.0008
637 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
638 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 169 0.0008
639 CONDITION AGGRAVATED 253 0.0008
640 DRUG DOSE OMISSION 137 0.0008
641 BIPOLAR DISORDER 9 0.0008
642 BACK INJURY 9 0.0008
643 PRODUCT PREPARATION ERROR 17 0.0008
644 ERUCTATION 16 0.0008
645 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
646 END STAGE RENAL DISEASE 15 0.0008
647 MUSCULOSKELETAL STIFFNESS 72 0.0008
648 WOUND INFECTION 9 0.0008
649 HYPOPHAGIA 21 0.0008
650 CHOKING 16 0.0008
651 PRODUCTIVE COUGH 39 0.0008
652 SCIATICA 13 0.0008
653 DIARRHOEA 526 0.0008
654 GASTROINTESTINAL DISORDER 73 0.0008
655 ASTHMA 92 0.0008
656 HYPERCALCAEMIA 10 0.0008
657 ARTHROPATHY 45 0.0008
658 RASH 352 0.0008
659 CYST 10 0.0008
660 ORTHOSTATIC HYPOTENSION 14 0.0008
661 JOINT STIFFNESS 21 0.0008
662 BLOOD PRESSURE DECREASED 53 0.0008
663 CARDIAC DISORDER 74 0.0008
664 PRODUCT AVAILABILITY ISSUE 18 0.0008
665 SKIN CANCER 17 0.0008
666 GASTRIC ULCER 15 0.0008
667 CHOLECYSTECTOMY 9 0.0008
668 MASS 11 0.0008
669 POST PROCEDURAL COMPLICATION 15 0.0008
670 RIB FRACTURE 16 0.0008
671 HEPATIC ENZYME INCREASED 53 0.0008
672 DYSPNOEA 440 0.0008
673 FLATULENCE 44 0.0008
674 EYELID OEDEMA 9 0.0008
675 MULTIPLE SCLEROSIS 37 0.0008
676 APPLICATION SITE PAIN 17 0.0008
677 SPLENOMEGALY 9 0.0008
678 AGITATION 56 0.0008
679 COVID-19 PNEUMONIA 9 0.0008
680 INCORRECT PRODUCT STORAGE 10 0.0008
681 GLOSSODYNIA 17 0.0008
682 ANKYLOSING SPONDYLITIS 10 0.0008
683 HYPOKINESIA 11 0.0008
684 INCONTINENCE 8 0.0008
685 MENTAL STATUS CHANGES 21 0.0008
686 INFLAMMATION 39 0.0008
687 CONJUNCTIVITIS 14 0.0008
688 PRODUCT DISTRIBUTION ISSUE 7 0.0008
689 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
690 JOINT RANGE OF MOTION DECREASED 10 0.0007
691 BREAST CANCER METASTATIC 8 0.0007
692 PRODUCT DOSE OMISSION ISSUE 218 0.0007
693 TRANSIENT ISCHAEMIC ATTACK 25 0.0007
694 ERYTHEMA 152 0.0007
695 BLOOD POTASSIUM INCREASED 12 0.0007
696 SPUTUM DISCOLOURED 7 0.0007
697 FLUSHING 75 0.0007
698 CHRONIC KIDNEY DISEASE 56 0.0007
699 RED BLOOD CELL COUNT DECREASED 21 0.0007
700 RASH ERYTHEMATOUS 35 0.0007
701 RENAL DISORDER 34 0.0007
702 APPLICATION SITE RASH 10 0.0007
703 GLAUCOMA 14 0.0007
704 LOSS OF CONSCIOUSNESS 93 0.0007
705 HERNIA 14 0.0007
706 ANHEDONIA 19 0.0007
707 DIZZINESS POSTURAL 7 0.0007
708 DRUG DISPENSING ERROR 11 0.0007
709 DRUG INEFFECTIVE 947 0.0007
710 GAIT INABILITY 24 0.0007
711 OSTEOMYELITIS 13 0.0007
712 OEDEMA PERIPHERAL 87 0.0007
713 PRODUCT PRESCRIBING ERROR 17 0.0007
714 DECREASED IMMUNE RESPONSIVENESS 7 0.0007
715 MENTAL DISORDER 31 0.0007
716 HEPATOMEGALY 7 0.0007
717 ABDOMINAL PAIN LOWER 18 0.0007
718 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 12 0.0007
719 SYSTEMIC LUPUS ERYTHEMATOSUS 25 0.0007
720 HEPATIC STEATOSIS 13 0.0007
721 SKIN DISCOLOURATION 32 0.0007
722 HERPES ZOSTER 40 0.0007
723 NEOPLASM 8 0.0007
724 INJECTION SITE URTICARIA 17 0.0007
725 INJECTION SITE SWELLING 53 0.0007
726 PRODUCT USE ISSUE 130 0.0007
727 BODY TEMPERATURE INCREASED 14 0.0007
728 ORAL CANDIDIASIS 9 0.0007
729 RESTLESSNESS 25 0.0007
730 MANIA 11 0.0007
731 VISUAL ACUITY REDUCED 22 0.0007
732 CONFUSIONAL STATE 107 0.0007
733 ECONOMIC PROBLEM 10 0.0007
734 MOOD SWINGS 21 0.0007
735 EATING DISORDER 14 0.0007
736 BLOOD UREA INCREASED 11 0.0007
737 RASH GENERALISED 17 0.0007
738 SKIN LESION 18 0.0007
739 LIVER FUNCTION TEST INCREASED 14 0.0007
740 SKIN EXFOLIATION 55 0.0007
741 DEAFNESS 17 0.0006
742 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 117 0.0006
743 INCORRECT DOSE ADMINISTERED 148 0.0006
744 DEEP VEIN THROMBOSIS 42 0.0006
745 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
746 FAECES DISCOLOURED 14 0.0006
747 VOMITING 302 0.0006
748 GASTRIC DISORDER 22 0.0006
749 ABDOMINAL PAIN 149 0.0006
750 MOBILITY DECREASED 46 0.0006
751 DYSKINESIA 26 0.0006
752 DEVICE OCCLUSION 9 0.0006
753 INJECTION SITE NODULE 7 0.0006
754 PRODUCT COMPLAINT 16 0.0006
755 MUSCLE ATROPHY 8 0.0006
756 DISORIENTATION 25 0.0006
757 WHITE BLOOD CELL COUNT DECREASED 68 0.0006
758 INJECTION SITE PRURITUS 42 0.0006
759 DECREASED APPETITE 145 0.0006
760 PULMONARY HYPERTENSION 13 0.0006
761 BLISTER 35 0.0006
762 MOVEMENT DISORDER 20 0.0006
763 LYMPHOCYTE COUNT DECREASED 11 0.0006
764 INJECTION SITE ERYTHEMA 77 0.0006
765 CHROMATURIA 14 0.0006
766 INJURY 43 0.0006
767 GASTRITIS 16 0.0006
768 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
769 WHEEZING 36 0.0006
770 HAEMATOCRIT DECREASED 12 0.0006
771 URINARY RETENTION 20 0.0006
772 SPINAL FRACTURE 12 0.0006
773 SEXUAL DYSFUNCTION 7 0.0006
774 PRODUCT PRESCRIBING ISSUE 13 0.0006
775 THROMBOSIS 48 0.0006
776 CELLULITIS 30 0.0006
777 PAIN OF SKIN 16 0.0006
778 OFF LABEL USE 519 0.0006
779 TASTE DISORDER 12 0.0006
780 ATAXIA 7 0.0006
781 PSORIASIS 77 0.0006
782 BLINDNESS 24 0.0006
783 CHOLECYSTITIS 7 0.0006
784 INJECTION SITE RASH 18 0.0006
785 MUSCLE RIGIDITY 7 0.0006
786 DYSPNOEA EXERTIONAL 22 0.0006
787 CORONARY ARTERY OCCLUSION 8 0.0006
788 PULMONARY EMBOLISM 55 0.0006
789 INJECTION SITE PAIN 177 0.0006
790 PSYCHOTIC DISORDER 17 0.0006
791 NO THERAPEUTIC RESPONSE 7 0.0006
792 DEMENTIA 16 0.0006
793 ARRHYTHMIA 27 0.0006
794 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
795 RESPIRATORY DISORDER 17 0.0006
796 INJECTION SITE MASS 21 0.0006
797 PNEUMOTHORAX 9 0.0006
798 BLINDNESS UNILATERAL 8 0.0006
799 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
800 SEIZURE 65 0.0006
801 THERAPEUTIC RESPONSE DECREASED 34 0.0006
802 INJECTION SITE DISCOLOURATION 7 0.0006
803 INFECTION 81 0.0006
804 PRODUCT USE IN UNAPPROVED INDICATION 138 0.0006
805 DERMATITIS ALLERGIC 7 0.0006
806 RHEUMATOID ARTHRITIS 63 0.0006
807 ECZEMA 29 0.0006
808 DRUG ADMINISTRATION ERROR 17 0.0006
809 INJECTION SITE REACTION 38 0.0006
810 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 10 0.0005
811 BLOOD GLUCOSE ABNORMAL 10 0.0005
812 INJECTION SITE INDURATION 7 0.0005
813 HAEMOPTYSIS 15 0.0005
814 BACTERIAL INFECTION 10 0.0005
815 EPISTAXIS 40 0.0005
816 SEDATION 14 0.0005
817 PULMONARY CONGESTION 7 0.0005
818 SARS-COV-2 TEST POSITIVE 7 0.0005
819 TACHYCARDIA 47 0.0005
820 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
821 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
822 MENSTRUATION IRREGULAR 14 0.0005
823 SYNCOPE 52 0.0005
824 PERICARDIAL EFFUSION 12 0.0005
825 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
826 FEMUR FRACTURE 16 0.0005
827 DRUG WITHDRAWAL SYNDROME 45 0.0005
828 GINGIVAL BLEEDING 7 0.0005
829 DERMATITIS ATOPIC 27 0.0005
830 BONE DENSITY DECREASED 16 0.0005
831 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
832 UNDERDOSE 37 0.0005
833 DYSARTHRIA 19 0.0005
834 GALLBLADDER DISORDER 9 0.0005
835 THERAPY INTERRUPTED 36 0.0005
836 PNEUMONIA 163 0.0005
837 PYREXIA 174 0.0005
838 OBESITY 8 0.0005
839 DEVICE ISSUE 45 0.0005
840 BLOOD GLUCOSE DECREASED 24 0.0005
841 CARDIAC FAILURE CONGESTIVE 40 0.0005
842 PLATELET COUNT DECREASED 53 0.0005
843 DEVICE EXPULSION 32 0.0005
844 DEVICE BREAKAGE 20 0.0005
845 PRODUCT STORAGE ERROR 43 0.0005
846 HALLUCINATION 37 0.0005
847 ADVERSE EVENT 45 0.0005
848 HAEMOGLOBIN DECREASED 50 0.0005
849 ABASIA 12 0.0005
850 INFUSION RELATED REACTION 32 0.0005
851 TOOTH LOSS 10 0.0005
852 INTENTIONAL DRUG MISUSE 10 0.0005
853 DERMATITIS 10 0.0005
854 COLITIS 18 0.0005
855 HALLUCINATION, VISUAL 10 0.0005
856 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
857 ABNORMAL DREAMS 13 0.0005
858 THERAPY NON-RESPONDER 21 0.0005
859 MULTIPLE SCLEROSIS RELAPSE 32 0.0005
860 RECTAL HAEMORRHAGE 20 0.0005
861 WOUND 13 0.0005
862 HYPOGLYCAEMIA 22 0.0005
863 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
864 ASPARTATE AMINOTRANSFERASE INCREASED 24 0.0005
865 LUNG INFECTION 7 0.0005
866 PREGNANCY 9 0.0004
867 NERVOUS SYSTEM DISORDER 14 0.0004
868 NEEDLE ISSUE 13 0.0004
869 EMOTIONAL DISTRESS 54 0.0004
870 TYPE 2 DIABETES MELLITUS 15 0.0004
871 OXYGEN SATURATION DECREASED 25 0.0004
872 OSTEONECROSIS OF JAW 11 0.0004
873 INJURY ASSOCIATED WITH DEVICE 9 0.0004
874 HALLUCINATION, AUDITORY 7 0.0004
875 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
876 ABNORMAL BEHAVIOUR 17 0.0004
877 HYPOTENSION 86 0.0004
878 ILL-DEFINED DISORDER 26 0.0004
879 HEPATIC CIRRHOSIS 8 0.0004
880 STAPHYLOCOCCAL INFECTION 14 0.0004
881 PULMONARY FIBROSIS 8 0.0004
882 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
883 ANAPHYLACTIC REACTION 23 0.0004
884 PANCREATITIS 22 0.0004
885 SKIN IRRITATION 19 0.0004
886 CEREBROVASCULAR ACCIDENT 70 0.0004
887 FREQUENT BOWEL MOVEMENTS 11 0.0004
888 NEOPLASM MALIGNANT 27 0.0004
889 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
890 RENAL FAILURE 53 0.0004
891 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
892 DEVICE DISLOCATION 17 0.0004
893 MYOCARDIAL INFARCTION 68 0.0004
894 INJECTION SITE WARMTH 8 0.0004
895 ACUTE MYELOID LEUKAEMIA 6 0.0004
896 PLASMA CELL MYELOMA 15 0.0004
897 TREATMENT NONCOMPLIANCE 21 0.0004
898 HAEMORRHAGE 40 0.0004
899 INCORRECT DOSE ADMINISTERED BY DEVICE 10 0.0004
900 PULMONARY OEDEMA 17 0.0004
901 ANAEMIA 71 0.0004
902 GENERAL PHYSICAL HEALTH DETERIORATION 43 0.0004
903 FRACTURE 7 0.0004
904 NEUTROPHIL COUNT DECREASED 15 0.0004
905 LUNG DISORDER 18 0.0004
906 BLOOD GLUCOSE INCREASED 69 0.0004
907 SEROTONIN SYNDROME 7 0.0004
908 DIABETES MELLITUS 27 0.0004
909 ERECTILE DYSFUNCTION 9 0.0004
910 EXPOSURE VIA SKIN CONTACT 9 0.0003
911 PANCREATIC CARCINOMA 10 0.0003
912 HAEMATOCHEZIA 19 0.0003
913 ACNE 26 0.0003
914 AGGRESSION 17 0.0003
915 HOSPITALISATION 52 0.0003
916 INJECTION SITE HAEMORRHAGE 27 0.0003
917 DISEASE PROGRESSION 40 0.0003
918 MOUTH ULCERATION 7 0.0003
919 PLEURAL EFFUSION 20 0.0003
920 HYPOKALAEMIA 15 0.0003
921 DRUG INTERACTION 51 0.0003
922 EXTRA DOSE ADMINISTERED 13 0.0003
923 HYPONATRAEMIA 18 0.0003
924 INTESTINAL OBSTRUCTION 12 0.0003
925 LUNG NEOPLASM MALIGNANT 13 0.0003
926 CARDIOVASCULAR DISORDER 8 0.0003
927 ANGINA PECTORIS 9 0.0003
928 DEVICE MALFUNCTION 22 0.0003
929 HYPOXIA 11 0.0003
930 ACUTE RESPIRATORY FAILURE 6 0.0003
931 PANCREATITIS ACUTE 7 0.0003
932 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
933 ANAPHYLACTIC SHOCK 8 0.0003
934 HAEMATOMA 8 0.0003
935 SKIN BURNING SENSATION 22 0.0003
936 BLOOD CREATININE INCREASED 20 0.0003
937 RENAL INJURY 9 0.0003
938 HYPERGLYCAEMIA 11 0.0003
939 SUICIDE ATTEMPT 18 0.0003
940 PALLOR 8 0.0003
941 LIVER DISORDER 13 0.0003
942 MATERNAL EXPOSURE DURING PREGNANCY 26 0.0003
943 COLITIS ULCERATIVE 13 0.0003
944 NO ADVERSE EVENT 52 0.0003
945 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
946 ACUTE KIDNEY INJURY 43 0.0003
947 PNEUMONIA ASPIRATION 7 0.0003
948 DRUG RESISTANCE 7 0.0003
949 BRADYCARDIA 14 0.0003
950 HAEMATURIA 9 0.0003
951 RENAL IMPAIRMENT 22 0.0003
952 SEPSIS 29 0.0003
953 BLOOD BILIRUBIN INCREASED 7 0.0003
954 BREAST CANCER 24 0.0003
955 DEVICE LEAKAGE 11 0.0003
956 RESPIRATORY DISTRESS 7 0.0003
957 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
958 COMA 12 0.0003
959 ABORTION SPONTANEOUS 10 0.0002
960 ACCIDENTAL OVERDOSE 9 0.0002
961 LEUKOPENIA 12 0.0002
962 CORONARY ARTERY DISEASE 7 0.0002
963 DELIRIUM 8 0.0002
964 ANGIOEDEMA 10 0.0002
965 EXPOSURE DURING PREGNANCY 14 0.0002
966 OVERDOSE 47 0.0002
967 MEDICATION ERROR 12 0.0002
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10 0.0002
969 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
970 NEOPLASM PROGRESSION 7 0.0002
971 C-REACTIVE PROTEIN INCREASED 7 0.0002
972 PANCYTOPENIA 10 0.0002
973 MALIGNANT NEOPLASM PROGRESSION 18 0.0002
974 RESPIRATORY FAILURE 12 0.0002
975 CARDIAC FAILURE 13 0.0002
976 CARDIAC ARREST 13 0.0002
977 CONVULSION 9 0.0002
978 TREATMENT FAILURE 13 0.0002
979 DEVICE DIFFICULT TO USE 10 0.0002
980 NEUTROPENIA 20 0.0001
981 INTERSTITIAL LUNG DISEASE 7 0.0001
982 DRUG DEPENDENCE 23 0.0001
983 DEATH 119 0.0001
984 THROMBOCYTOPENIA 15 0.0001
985 DRUG DOSE OMISSION BY DEVICE 9 0.0001
986 TOXICITY TO VARIOUS AGENTS 19 0.0001
987 PROSTATE CANCER 8 0.0001
988 DRUG ABUSE 8 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001